Generate a tailored SOP for Dr. Irfan Asangani. Improve your application with a focused, well-structured draft.
Irfan Asangani is an Associate Professor in the Department of Cancer Biology at the Perelman School of Medicine, University of Pennsylvania. His research focuses on the various molecular mechanisms underlying prostate cancer progression, particularly the role of chromatin modifying enzymes and transcriptional co-activators in this process. Asangani's work aims to clarify the importance of androgen receptor signaling in tumor development, emphasizing the impact of chromatin regulation and non-coding RNA interactions in cancer. He is dedicated to identifying new therapeutic targets within the context of prostate cancer and works towards developing novel strategies for treatment in castration-resistant prostate cancer.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.